ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Combined inhibition of DOT1L and BCL-2 induces synergistic anti-leukemic effects in MLL-rearranged acute myeloid leukemia via suppression of the PI3K/AKT pathway.

Yabei Zuo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.